Literature DB >> 8859612

Extramedullary haematopoiesis in thalassaemia: results of radiotherapy: a report of three patients.

K Pistevou-Gompaki1, G Skaragas, P Paraskevopoulos, K Kotsa, E Repanta.   

Abstract

Extramedullary haematopoiesis is sometimes encountered in severe anaemia. Rarely, it may cause neurological symptoms, leading to spinal cord or cauda equina compression. Three patients with thalassaemia intermedia, who developed neurological complications, are described. The diagnoses were based on the clinical findings, computed tomography and magnetic resonance imaging. Small doses of radiotherapy (10-20 Gy in 5-10 fractions) relieved symptoms in all of these patients. Our experience supports the role of radiation therapy as a treatment for this complication.

Entities:  

Mesh:

Year:  1996        PMID: 8859612     DOI: 10.1016/s0936-6555(96)80120-8

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


  5 in total

1.  Paratracheal extramedullary hematopoiesis.

Authors:  C Kurtman; M K Ozbilgin; M N Andrieu; B Celebioğlu
Journal:  Int J Hematol       Date:  2001-06       Impact factor: 2.490

2.  Fifteen-year follow-up of a patient with beta thalassaemia and extramedullary haematopoietic tissue compressing the spinal cord.

Authors:  P Niggemann; T Krings; F Hans; A Thron
Journal:  Neuroradiology       Date:  2005-04-06       Impact factor: 2.804

Review 3.  Paraspinal extramedullary hematopoiesis in patients with thalassemia intermedia.

Authors:  Rachid Haidar; Hani Mhaidli; Ali T Taher
Journal:  Eur Spine J       Date:  2010-03-05       Impact factor: 3.134

Review 4.  Progressive spinal cord compression due to epidural extramedullary hematopoiesis in thalassemia intermedia. A case report and literature review.

Authors:  U Ghieda; M Elshimy; A H El Beltagi
Journal:  Neuroradiol J       Date:  2013-01-19

5.  Effect of hypertransfusion on extramedullary hematopoietic compression mass in thalassemia major: a case report.

Authors:  Mohammadreza Emamhadi; Ahmad Alizadeh
Journal:  Iran J Radiol       Date:  2012-09-17       Impact factor: 0.212

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.